Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Indiana Ups State Power To Limit Pseudoephedrine Product Sales

Executive Summary

DEA has the authority and expertise to conduct stress tests on pseudoephedrine formulations, says CHPA state government director Carol Gutierrez. But Indiana allows its pharmacy board to say whether a PSE product is tamper-resistant.


Related Content

OTC Drug Industry Could Stand To Gain With 'Pragmatist' In White House
Perrigo Deal Makes Extraction-Resistant PSE A Two-Player Competition
Tamper-Resistant PSE Takes Big Pharma Stage: Bayer Licenses Acura’s Formulation
To Curb PSE Diversion, Retailers Lead By Example With Emphasis On Tamper-Resistant Products
Georgia Limits OTC Pseudoephedrine Sales To Pharmacies


Related Companies




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Add a personalized Question to your Analyst